自身免疫疾病治疗人数多、往往需终身用药，是全球第二大药物市场，新型疗法快速迭代。传统自免药物主要是免疫抑制剂与改善病情抗风湿药等，长期使用存在较大副反应。全球“药王”阿达木单抗（TNFα）广谱覆盖了银屑病、类风关等多种自免疾病，长周期用药下市场巨大。尽管随着新疗法更迭、生物类似药进入市场，2022年阿达木单抗仍销售212.4亿美元。近年来，新靶点、新剂型、长周期的自免新药不断取得突破，细胞治疗展现一针治愈红斑狼疮的潜力。技术的迭代为新进入者创造机遇。

Biosurfactants are known as surface-active compounds that can be synthesized by a selected number of natural and biobased sources. Biosurfactants are popular for their biodegradability and low eco-toxicity. Besides biodegradability, low toxicity & high production potential, biosurfactants have a high surface and interfacial activity. Biosurfactants are commercially produced from natural sources such as vegetable oil, glycerol and glucose by the addition of a non-pathogenic microorganisms.

The global acute pancreatitis market is estimated to grow at a CAGR of 5.7% from 2022 to 2030. Key factors driving the market growth are rise in pancreatic cancer cases due to acute pancreatitis and rising incidences of diabetes following acute pancreatitis. However, side-effects of pancreatitis and pancreatic cancer treatments hinders the market growth.

The automated external defibrillators market is estimated to grow at a CAGR of 4.5% from 2020 to 2030. Key factors driving the market growth are increasing prevalence of cardiovascular diseases and rising training and awareness programs on automated external defibrillators. Whereas performance issues related to automated external defibrillators is hindering the market growth.

The global endoscopy procedures market is estimated to grow at a CAGR of 7.0% from 2022 to 2030. Key factors driving the market growth are growing preference for minimally invasive surgeries and increasing prevalence of cancer are the key factors driving the market. However, the risks of infections associated with endoscopic procedures hamper the market growth.

The global endoscopy procedures market is estimated to grow at a CAGR of 7.0% from 2022 to 2030. Key factors driving the market growth are growing preference for minimally invasive surgeries and increasing prevalence of cancer are the key factors driving the market. However, the risks of infections associated with endoscopic procedures hamper the market growth.

Biosurfactants are known as surface-active compounds that can be synthesized by a selected number of natural and biobased sources. Biosurfactants are popular for their biodegradability and low eco-toxicity. Besides biodegradability, low toxicity & high production potential, biosurfactants have a high surface and interfacial activity. Biosurfactants are commercially produced from natural sources such as vegetable oil, glycerol and glucose by the addition of a nonpathogenic microorganisms. Biosurfactants are extracted from natural sources and are also expected to be an alternative to petrochemicals.

The Global bariatric surgeries market is estimated to grow at a CAGR of 15.9% from 2022 to 2030. Key factors driving the market growth are the increasing prevalence of obesity and growing demand for minimally invasive surgeries are driving the market growth. However, the stringent regulatory policies and increase in safety concerns restrain the market growth.

The global acute pancreatitis market is estimated to grow at a CAGR of 5.7% from 2022 to 2030. Key factors driving the market growth are rise in pancreatic cancer cases due to acute pancreatitis and rising incidences of diabetes following acute pancreatitis. However, side-effects of pancreatitis and pancreatic cancer treatments hinders the market growth.

The automated external defibrillators market is estimated to grow at a CAGR of 4.5% from 2020 to 2030. Key factors driving the market growth are increasing prevalence of cardiovascular diseases and rising training and awareness programs on automated external defibrillators. Whereas performance issues related to automated external defibrillators is hindering the market growth.

The global aesthetic lasers market is estimated to grow at a CAGR of 12.3% from 2022 to 2030. Key factors driving the market growth are growing adoption of non-invasive aesthetic procedures and increasing prevalence of skin disorders along with growing awareness about beauty devices. However, risks and complications associated with procedures and stringent safety regulations hinders the market growth.

The global aesthetic lasers market is estimated to grow at a CAGR of 12.3% from 2022 to 2030. Key factors driving the market growth are growing adoption of non-invasive aesthetic procedures and increasing prevalence of skin disorders along with growing awareness about beauty devices. However, risks and complications associated with procedures and stringent safety regulations hinders the market growth.

The Global bariatric surgeries market is estimated to grow at a CAGR of 15.9% from 2022 to 2030. Key factors driving the market growth are the increasing prevalence of obesity and growing demand for minimally invasive surgeries are driving the market growth. However, the stringent regulatory policies and increase in safety concerns restrain the market growth.

The global cerebrospinal fluid management market is estimated to grow at a CAGR of 5.3% from 2022 to 2030. Key factors driving the market growth are increasing incidences of CSF leak and growing developments for CSF management products. However, the risk associated with CSF shunts hinders the market growth.

The healthcare landscape has undergone a remarkable transformation with the emergence of digital biomarkers. Digital biomarkers represent a pivotal shift in how healthcare professionals collect, analyze, and act upon patient data, fundamentally altering how diseases are diagnosed, treated, and monitored.

The global aesthetic lasers market is estimated to grow at a CAGR of 12.3% from 2022 to 2030. Key factors driving the market growth are growing adoption of non-invasive aesthetic procedures and increasing prevalence of skin disorders along with growing awareness about beauty devices. However, risks and complications associated with procedures and stringent safety regulations hinders the market growth.

The global aesthetic lasers market is estimated to grow at a CAGR of 12.3% from 2022 to 2030. Key factors driving the market growth are growing adoption of non-invasive aesthetic procedures and increasing prevalence of skin disorders along with growing awareness about beauty devices. However, risks and complications associated with procedures and stringent safety regulations hinders the market growth.

The global cerebrospinal fluid management market is estimated to grow at a CAGR of 5.3% from 2022 to 2030. Key factors driving the market growth are increasing incidences of CSF leak and growing developments for CSF management products. However, the risk associated with CSF shunts hinders the market growth.

The automated external defibrillators market is estimated to grow at a CAGR of 4.5% from 2020 to 2030. Key factors driving the market growth are increasing prevalence of cardiovascular diseases and rising training and awareness programs on automated external defibrillators. Whereas performance issues related to automated external defibrillators is hindering the market growth.

The Global bariatric surgeries market is estimated to grow at a CAGR of 15.9% from 2022 to 2030. Key factors driving the market growth are the increasing prevalence of obesity and growing demand for minimally invasive surgeries are driving the market growth. However, the stringent regulatory policies and increase in safety concerns restrain the market growth.